OpenURL Connection Search

Select item for more details and to access through your institution.

Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1874, doi. 10.1007/s10147-022-02246-1
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Nagasawa, Takayuki;
- Kagabu, Masahiro;
- Baba, Tsukasa;
- Shigeto, Tatsuhiko;
- Matsumura, Yukiko;
- Shimizu, Dai;
- Terada, Yukihiro;
- Seino, Manabu;
- Ohta, Tsuyoshi;
- Nagase, Satoru;
- Shigeta, Shogo;
- Tokunaga, Hideki;
- Shimada, Muneaki;
- Kaiho-Sakuma, Michiko;
- Furukawa, Shigenori;
- Soeda, Shu;
- Watanabe, Takafumi;
- Takahashi, Fumiaki
Publication type:
Article
Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.
Published in:
International Journal of Clinical Oncology, 2014, v. 19, n. 5, p. 897, doi. 10.1007/s10147-013-0627-5
By:
- Takano, Tadao;
- Niikura, Hitoshi;
- Ito, Kiyoshi;
- Nagase, Satoru;
- Utsunomiya, Hiroki;
- Otsuki, Takeo;
- Toyoshima, Masafumi;
- Tokunaga, Hideki;
- Kaiho-Sakuma, Michiko;
- Shiga, Naomi;
- Nagai, Tomoyuki;
- Tanaka, Sota;
- Otsuki, Ai;
- Kurosawa, Hiroki;
- Shigeta, Shogo;
- Tsuji, Keita;
- Yamaguchi, Takuhiro;
- Yaegashi, Nobuo
Publication type:
Article
Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
Published in:
International Journal of Clinical Oncology, 2014, v. 19, n. 1, p. 133, doi. 10.1007/s10147-013-0534-9
By:
- Tanaka, Sota;
- Nagase, Satoru;
- Kaiho-Sakuma, Michiko;
- Nagai, Tomoyuki;
- Kurosawa, Hiroki;
- Toyoshima, Masafumi;
- Tokunaga, Hideki;
- Otsuki, Takeo;
- Utsunomiya, Hiroki;
- Takano, Tadao;
- Niikura, Hitoshi;
- Ito, Kiyoshi;
- Yaegashi, Nobuo
Publication type:
Article
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
Published in:
2017
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Omi, Hideo;
- Kagabu, Masahiro;
- Honda, Tatsuya;
- Futagami, Masayuki;
- Yokoyama, Yoshihito;
- Kaiho, Michiko;
- Tokunaga, Hideki;
- Otsuki, Takeo;
- Takano, Tadao;
- Yaegashi, Nobuo;
- Kojimahara, Takanobu;
- Ohta, Tsuyoshi;
- Nagase, Satoru;
- Soeda, Shu;
- Watanebe, Takafumi;
- Nishiyama, Hiroshi;
- Sugiyama, Toru
Publication type:
journal article
A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
Published in:
Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 895, doi. 10.1007/s00280-014-2418-8
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Kaido, Yoshitaka;
- Omi, Hideo;
- Yokoyama, Yoshihito;
- Mizunuma, Hideki;
- Kaiho, Michiko;
- Otsuki, Takeo;
- Takano, Tadao;
- Yaegashi, Nobuo;
- Nishiyama, Hiroshi;
- Fujimori, Keiya;
- Sugiyama, Toru
Publication type:
Article
Small Cell Carcinoma of the Uterine Cervix: Clinical Outcome of Concurrent Chemoradiotherapy with a Multidrug Regimen.
Published in:
Tohoku Journal of Experimental Medicine, 2013, v. 229, n. 1, p. 75, doi. 10.1620/tjem.229.75
By:
- Tokunaga, Hideki;
- Nagase, Satoru;
- Yoshinaga, Kosuke;
- Tanaka, Sota;
- Nagai, Tomoyuki;
- Kurosawa, Hiroki;
- Kaiho-Sakuma, Michiko;
- Toyoshima, Masafumi;
- Otsuki, Takeo;
- Utsunomiya, Hiroki;
- Takano, Tadao;
- Niikura, Hitoshi;
- Ito, Kiyoshi;
- Yaegashi, Nobuo
Publication type:
Article

Found: 6

Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).

Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.

Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.

A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).

Small Cell Carcinoma of the Uterine Cervix: Clinical Outcome of Concurrent Chemoradiotherapy with a Multidrug Regimen.